Literature DB >> 21104606

Anti-infective activities of Pelargonium sidoides (EPS® 7630): effects of induced NO production on Leishmania major in infected macrophages and antiviral effects as assessed in a fibroblast-virus protection assay.

Carsten Thäle1, Albrecht Ferdinand Kiderlen, Herbert Kolodziej.   

Abstract

EPs® 7630 is an aqueous-ethanolic extract of the roots of Pelargonium sidoides, employed in the treatment of upper respiratory tract infections. Its anti-infective activity is supposed to be associated with the activation of the nonspecific immune system. Using Leishmania major GFP-infected murine BMMΦ, the NO production of EPs® 7630-activated macrophages was correlated with the reduction of the GFP signal measured at single cell levels using flow cytometry. The anti-infectious effect of EPs® 7630 (3-10 µg/mL) on its own (NO production: 4-13 µM; signal reduction: 25-73 %) was less prominent than that in combination with IFN- γ (100 U/mL) (NO production: 20-27 µM; signal reduction: 35-78 %). Furthermore, supernatants of EPs® 7630-stimulated BMMΦ (10 µg/mL) significantly reduced the cytopathic effect of EMCV on L929 fibroblasts (antiviral activity 80 U/mL) when compared with an IFN- γ standard (100 U/mL). Direct addition of EPs® 7630 to L929 did not mediate cytoprotective effects. The antiviral components induced in BMMΦ by EPs® 7630 remain to be identified. Detection of any IFNs by ELISA was unsuccessful, which may be due to their very low concentrations in cell supernatants. The current data provide convincing support for the induction of anti-infectious responses by EPs® 7630. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21104606     DOI: 10.1055/s-0030-1250567

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  7 in total

Review 1.  Antimicrobial, Antiviral and Immunomodulatory Activity Studies of Pelargonium sidoides (EPs® 7630) in the Context of Health Promotion.

Authors:  Herbert Kolodziej
Journal:  Pharmaceuticals (Basel)       Date:  2011-10-10

Review 2.  Pelargonium sidoides extract EPs 7630: a review of its clinical efficacy and safety for treating acute respiratory tract infections in children.

Authors:  Domenico Careddu; Andrea Pettenazzo
Journal:  Int J Gen Med       Date:  2018-03-08

3.  The herbal extract EPs® 7630 increases the antimicrobial airway defense through monocyte-dependent induction of IL-22 in T cells.

Authors:  Katrin Witte; Egon Koch; Hans-Dieter Volk; Kerstin Wolk; Robert Sabat
Journal:  J Mol Med (Berl)       Date:  2020-09-19       Impact factor: 4.599

4.  Antiviral and Immunomodulatory Effects of Pelargonium sidoides DC. Root Extract EPs® 7630 in SARS-CoV-2-Infected Human Lung Cells.

Authors:  Jan Papies; Jackson Emanuel; Nicolas Heinemann; Žarko Kulić; Simon Schroeder; Beate Tenner; Martin D Lehner; Georg Seifert; Marcel A Müller
Journal:  Front Pharmacol       Date:  2021-10-25       Impact factor: 5.810

5.  Flavonoids for Treating Viral Acute Respiratory Tract Infections: A Systematic Review and Meta-Analysis of 30 Randomized Controlled Trials.

Authors:  Jia Yao; Yuan Zhang; Xian-Zhe Wang; Jia Zhao; Zhao-Jun Yang; Yu-Ping Lin; Lu Sun; Qi-Yun Lu; Guan-Jie Fan
Journal:  Front Public Health       Date:  2022-02-16

6.  The Pelargonium sidoides Extract EPs 7630 Drives the Innate Immune Defense by Activating Selected MAP Kinase Pathways in Human Monocytes.

Authors:  Katrin Witte; Egon Koch; Hans-Dieter Volk; Kerstin Wolk; Robert Sabat
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240

Review 7.  Medicinal properties and conservation of Pelargonium sidoides DC.

Authors:  Mack Moyo; Johannes Van Staden
Journal:  J Ethnopharmacol       Date:  2014-01-21       Impact factor: 4.360

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.